Gender Differences in the Diagnosis of Dyslipidemia: ESCARVAL-GENERO.
Por:
Soriano-Maldonado C, Lopez-Pineda A, Orozco-Beltran D, Quesada JA, Alfonso-Sanchez JL, Pallarés-Carratalá V, Navarro-Perez J, Gil-Guillen VF, Martin-Moreno JM and Carratala-Munuera C
Publicada:
25 nov 2021
Ahead of Print:
25 nov 2021
Resumen:
Evidence shows that objectives for detecting and controlling dyslipidemia are not being effectively met, and outcomes differ between men and women. This study aimed to assess gender-related differences in diagnostic inertia around dyslipidemia. This ambispective, epidemiological, cohort registry study included adults who presented to public primary health care centers in a Spanish region from 2008 to 2012, with dyslipidemia and without cardiovascular disease. Diagnostic inertia was defined as the registry of abnormal diagnostic parameters-but no diagnosis-on the person's health record in a window of six months from inclusion. A total of 58,970 patients were included (53.7% women) with a mean age of 58.4 years in women and 57.9 years in men. The 6358 (20.1%) women and 4312 (15.8%) men presenting diagnostic inertia had a similar profile, although in women the magnitude of the association with younger age was larger. Hypertension showed a larger association with diagnostic inertia in women than in men (prevalence ratio 1.81 vs. 1.56). The overall prevalence of diagnostic inertia in dyslipidemia is high, especially in women. Both men and women have a higher risk of cardiovascular morbidity and mortality.
Filiaciones:
Soriano-Maldonado C:
Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
:
Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
:
Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
:
Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Alfonso-Sanchez JL:
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain
Preventive Medicine Service, General University Hospital Consortium, 46014 Valencia, Spain
Pallarés-Carratalá V:
Health Surveillance Unit, Castellon Mutual Insurance Union, 12004 Castellon, Spain
Department of Medicine, Jaume I University, 12071 Castellon, Spain
Navarro-Perez J:
Biomedical Research Institute INCLIVA, Hospital Clinico Universitario de Valencia, University of Valencia, 46010 Valencia, Spain
Ciber of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain
:
Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Martin-Moreno JM:
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain
Biomedical Research Institute INCLIVA, Hospital Clinico Universitario de Valencia, University of Valencia, 46010 Valencia, Spain
:
Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Open Access
FULL TEXT
 |
Published Version |
|
| No Accesible |
|